Quel avenir pour la transfusion ?

Abstract

AbstractBlood transfusion is still a support in traumatic hemorrhagic emergencies, as it has been for over a century, and has become so in certain medical emergencies. The profile of blood donors has evolved over the course of this century, most notably since the second half of the 20th century. However, the profile of recipients has also changed considerably and is constantly evolving, particularly in situations where transfusion is allocated through hemotherapy. In support of this, blood products benefit from technical advances both in their production and in the prevention of the undesirable effects they can cause. The quality and monitoring of blood products and their application has also led to new disciplines, such as hemovigilance, and new protocols, such as the implementation of optimized blood management and personalized blood management. Two issues remain unresolved, however: on the one hand, the promotion of more standardized and therefore more informative clinical studies, and on the other, the expansion of innovative, disruptive technologies that could one day replace transfusion. In these circumstances, blood transfusion is irreplaceable and will probably remain so for many decades to come.